Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and related challenge of timely patient access to lifesaving interventions such as transcatheter aortic valve replacement (TAVR) procedures. The paper, “The Rising Tide of Cardiovascular Disease: A Looming Crisis for Cardiovascular Intervention Resources” notes an 8% increase in demand for inpatient procedures and a 25% increase for outpatient procedures over the next 10 years. “Hospitals struggling...